Standard
Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment. / Kolko, Miriam; Gazzard, Gus; Baudouin, Christophe; Beier, Sofie; Brignole-Baudouin, Françoise; Cvenkel, Barbara; Fineide, Fredrik; Hedengran, Anne; Hommer, Anton; Jespersen, Erik; Messmer, Elisabeth M.; Murthy, Rachna; Sullivan, Amy Gallant; Tatham, Andrew J.; Utheim, Tor Paaske; Vittrup, Marijke; Sullivan, David A.
In:
Ocular Surface, Vol. 29, 2023, p. 456-468.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Kolko, M, Gazzard, G, Baudouin, C, Beier, S, Brignole-Baudouin, F, Cvenkel, B, Fineide, F
, Hedengran, A, Hommer, A, Jespersen, E, Messmer, EM, Murthy, R, Sullivan, AG, Tatham, AJ, Utheim, TP, Vittrup, M & Sullivan, DA 2023, '
Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment',
Ocular Surface, vol. 29, pp. 456-468.
https://doi.org/10.1016/j.jtos.2023.05.012
APA
Kolko, M., Gazzard, G., Baudouin, C., Beier, S., Brignole-Baudouin, F., Cvenkel, B., Fineide, F.
, Hedengran, A., Hommer, A., Jespersen, E., Messmer, E. M., Murthy, R., Sullivan, A. G., Tatham, A. J., Utheim, T. P., Vittrup, M., & Sullivan, D. A. (2023).
Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment.
Ocular Surface,
29, 456-468.
https://doi.org/10.1016/j.jtos.2023.05.012
Vancouver
Kolko M, Gazzard G, Baudouin C, Beier S, Brignole-Baudouin F, Cvenkel B et al.
Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment.
Ocular Surface. 2023;29:456-468.
https://doi.org/10.1016/j.jtos.2023.05.012
Author
Kolko, Miriam ; Gazzard, Gus ; Baudouin, Christophe ; Beier, Sofie ; Brignole-Baudouin, Françoise ; Cvenkel, Barbara ; Fineide, Fredrik ; Hedengran, Anne ; Hommer, Anton ; Jespersen, Erik ; Messmer, Elisabeth M. ; Murthy, Rachna ; Sullivan, Amy Gallant ; Tatham, Andrew J. ; Utheim, Tor Paaske ; Vittrup, Marijke ; Sullivan, David A. / Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment. In: Ocular Surface. 2023 ; Vol. 29. pp. 456-468.
Bibtex
@article{a8cff162d4394a9da58bc023859d7526,
title = "Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment",
author = "Miriam Kolko and Gus Gazzard and Christophe Baudouin and Sofie Beier and Fran{\c c}oise Brignole-Baudouin and Barbara Cvenkel and Fredrik Fineide and Anne Hedengran and Anton Hommer and Erik Jespersen and Messmer, {Elisabeth M.} and Rachna Murthy and Sullivan, {Amy Gallant} and Tatham, {Andrew J.} and Utheim, {Tor Paaske} and Marijke Vittrup and Sullivan, {David A.}",
note = "Funding Information: Tor Paaske Utheim - Co-owner of The Norwegian dry eye clinic and the Clinic of eye health, Oslo, Norway, which delivers talks for and/or receives financial support from: ABIGO, Alcon, Allergan, AMWO, Bausch + Lomb, Bayer, European school for advanced studies in ophthalmology, InnZ Medical, Medilens Nordic, Medistim, Novartis, Santen, Specsavers, Shire Pharmaceuticals, Laboratoire Th{\'e}a. He has served on the global scientific advisory board for Novartis and Alcon as well as the European advisory board for Shire Pharmaceuticals. Funding Information: TFOS expresses its appreciation to Julie Karimi (www.jaka.it), Sabrina Zappia (www.citynetonline.it) and Jeremy Chung Bo Chiang (Sydney, Australia) for their outstanding assistance. TFOS also thanks the following industry partners who supported this TFOS Experts' Meeting with unrestricted donations: Santen, Bausch + Lomb, Domp{\'e}, Glaukos, URSAPHARM, Laboratoires Th{\'e}a and VISUfarma.",
year = "2023",
doi = "10.1016/j.jtos.2023.05.012",
language = "English",
volume = "29",
pages = "456--468",
journal = "The Ocular Surface",
issn = "1542-0124",
publisher = "Elsevier",
}
RIS
TY - JOUR
T1 - Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment
AU - Kolko, Miriam
AU - Gazzard, Gus
AU - Baudouin, Christophe
AU - Beier, Sofie
AU - Brignole-Baudouin, Françoise
AU - Cvenkel, Barbara
AU - Fineide, Fredrik
AU - Hedengran, Anne
AU - Hommer, Anton
AU - Jespersen, Erik
AU - Messmer, Elisabeth M.
AU - Murthy, Rachna
AU - Sullivan, Amy Gallant
AU - Tatham, Andrew J.
AU - Utheim, Tor Paaske
AU - Vittrup, Marijke
AU - Sullivan, David A.
N1 - Funding Information:
Tor Paaske Utheim - Co-owner of The Norwegian dry eye clinic and the Clinic of eye health, Oslo, Norway, which delivers talks for and/or receives financial support from: ABIGO, Alcon, Allergan, AMWO, Bausch + Lomb, Bayer, European school for advanced studies in ophthalmology, InnZ Medical, Medilens Nordic, Medistim, Novartis, Santen, Specsavers, Shire Pharmaceuticals, Laboratoire Théa. He has served on the global scientific advisory board for Novartis and Alcon as well as the European advisory board for Shire Pharmaceuticals.
Funding Information:
TFOS expresses its appreciation to Julie Karimi (www.jaka.it), Sabrina Zappia (www.citynetonline.it) and Jeremy Chung Bo Chiang (Sydney, Australia) for their outstanding assistance. TFOS also thanks the following industry partners who supported this TFOS Experts' Meeting with unrestricted donations: Santen, Bausch + Lomb, Dompé, Glaukos, URSAPHARM, Laboratoires Théa and VISUfarma.
PY - 2023
Y1 - 2023
U2 - 10.1016/j.jtos.2023.05.012
DO - 10.1016/j.jtos.2023.05.012
M3 - Journal article
C2 - 37302545
AN - SCOPUS:85163798187
VL - 29
SP - 456
EP - 468
JO - The Ocular Surface
JF - The Ocular Surface
SN - 1542-0124
ER -
